Publications

BibTex format

@article{Kallol:2023:10.1089/scd.2022.0255,
author = {Kallol, S and Martin-Sancho, L and Morey, R and Aisagbonhi, O and Pizzo, D and Meads, M and Chanda, SK and Soncin, F},
doi = {10.1089/scd.2022.0255},
journal = {Stem Cells and Development},
pages = {225--236},
title = {Activation of the interferon pathway in trophoblast cells productively infected with SARS-CoV-2},
url = {http://dx.doi.org/10.1089/scd.2022.0255},
volume = {32},
year = {2023}
}

Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - SARS-CoV-2 infection during pregnancy has been associated with poor maternal and neonatal outcomes and placental defects. The placenta, which acts as a physical and immunological barrier at the maternal–fetal interface, is not established until the end of the first trimester. Therefore, localized viral infection of the trophoblast compartment early in gestation could trigger an inflammatory response resulting in altered placental function and consequent suboptimal conditions for fetal growth and development. In this study, we investigated the effect of SARS-CoV-2 infection in early gestation placentae using placenta-derived human trophoblast stem cells (TSCs), a novel in vitro model, and their extravillous trophoblast (EVT) and syncytiotrophoblast (STB) derivatives. SARS-CoV-2 was able to productively replicate in TSC-derived STB and EVT, but not undifferentiated TSCs, which is consistent with the expression of SARS-CoV-2 entry host factors, ACE2 (angiotensin-converting enzyme 2) and TMPRSS2 (transmembrane cellular serine protease) in these cells. In addition, both TSC-derived EVT and STB infected with SARS-CoV-2 elicited an interferon-mediated innate immune response. Combined, these results suggest that placenta-derived TSCs are a robust in vitro model to investigate the effect of SARS-CoV-2 infection in the trophoblast compartment of the early placenta and that SARS-CoV-2 infection in early gestation activates the innate immune response and inflammation pathways. Therefore, placental development could be adversely affected by early SARS-CoV-2 infection by directly infecting the developing differentiated trophoblast compartment, posing a higher risk for poor pregnancy outcomes.
AU  - Kallol,S
AU  - Martin-Sancho,L
AU  - Morey,R
AU  - Aisagbonhi,O
AU  - Pizzo,D
AU  - Meads,M
AU  - Chanda,SK
AU  - Soncin,F
DO  - 10.1089/scd.2022.0255
EP  - 236
PY  - 2023///
SN  - 1547-3287
SP  - 225
TI  - Activation of the interferon pathway in trophoblast cells productively infected with SARS-CoV-2
T2  - Stem Cells and Development
UR  - http://dx.doi.org/10.1089/scd.2022.0255
UR  - https://www.liebertpub.com/doi/10.1089/scd.2022.0255
VL  - 32
ER  -

Download

Dr Laura Martin-Sancho

Contact

Location

Summary

Citation

BibTex format

RIS format (EndNote, RefMan)